Key result
Multimodal therapy yields partial tumor response but no visual recovery in intracranial Ewing-like sarcoma.
Why the study?
Primary intracranial Ewing sarcoma or Ewing-like sarcoma is an exceptionally rare malignant tumor with non-specific radiological features that can mimic other aggressive neoplasms and lead to diagnostic delay.
Case Report (n=1)
Primary intracranial Ewing-like sarcoma can present with severe and irreversible visual impairment, highlighting the need for early neuroimaging in patients with persistent seizures.
Answers are grounded in this paper and cite their sources.
Warns of irreversible visual loss despite partial response; leaves open optimal regimens for this rare tumor.
Primary intracranial Ewing sarcoma / Ewing-like sarcoma is an exceptionally rare malignant small round cell tumor. Its radiological appearance is often non-specific and may mimic other aggressive intracranial neoplasms, leading to diagnostic delay. We report the case of a young adult presenting with progressive headaches and recurrent generalized tonic–clonic seizures for six months, followed by rapid bilateral visual loss. Neurological examination revealed papilledema and decreased visual acuity, prompting brain imaging. MRI demonstrated a large aggressive frontal mass with heterogeneous enhancement, marked diffusion restriction, meningeal involvement, and significant mass effect with midline crossing. Initial staging showed no extracranial disease. Histopathology revealed a small round cell tumor with strong membranous CD99 expression consistent with an intracranial Ewing-like sarcoma. The patient received multimodal treatment including radiotherapy and VDC/IE chemotherapy. Follow-up imaging demonstrated partial tumor response. However, no visual recovery occurred, and the patient remained limited to light and shadow perception. This case highlights the diagnostic challenges of primary intracranial Ewing-like sarcoma and its potential to present with severe and irreversible visual impairment. Early neuroimaging in patients with persistent seizures is essential to avoid diagnostic delay, and molecular confirmation remains crucial for future cases.
No takes yet. Share an insight, caveat, or question.
Guerrouaz et al. (2026) conducted a case report in Primary intracranial Ewing-like sarcoma (n=1). Radiotherapy and VDC/IE chemotherapy was evaluated on Tumor response and visual recovery. Multimodal treatment with radiotherapy and VDC/IE chemotherapy achieved partial tumor response but no visual recovery in a young adult with primary intracranial Ewing-like sarcoma.
Synapse has enriched 10 related papers. Consider them for comparative context: